Rita Marreiros, Ph.D. is an ambitious neuroscientist and life science consultant with a diverse background spanning academia, biotech, and non-profit sectors. Her career began with a postdoctoral fellowship in a Nobel Prize laureate setting the stage for a career dedicated to driving innovation and translating cutting-edge research into impactful therapeutic solutions.

 

With extensive experience in developing iPSC-derived neuronal models and RNA-based assays, Rita is dedicated to advancing preclinical neuroscience programs. Her expertise has been honed across varied environments, from academic research at UCSF's Institute for Neurodegenerative Diseases to biotech companies like Creyon Bio, where she established scalable workflows for drug discovery. Her commitment extends to the non-profit sector, where she has contributed her strategic insights to organizations like Chan Zuckenberg Biohub and the Biotech Connection Bay Area.

 

Rita's expertise spans neurodegeneration, RNA biology, and molecular neuroscience, underpinned by her translational research, target validation, and high-throughput screening skills. Most recently, as a Life Science Consultant, she partnered with the Michael J. Fox Foundation to identify and prioritize symptomatic targets for Parkinson's Disease, showcasing her ability to drive therapeutic innovation and inform strategic decisions.

 

At Atoll, Rita leverages her deep scientific knowledge, strategic thinking, and cross-sector experience to conduct comprehensive scientific due diligence and foster strong client relationships in the biotech and life sciences sectors. Her ability to evaluate therapeutic opportunities, analyze competitive landscapes, and navigate regulatory pathways ensures that Atoll's clients and investors benefit from well-informed advisory services, maximizing their potential for success in the dynamic world of life science investment.